๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients

โœ Scribed by Kenji Jin-no; Masahito Tanimizu; Ichinosuke Hyodo; Yoshiyuki Nishikawa; Yasushi Hosokawa; Hisashi Endo; Toshihiko Doi; Koichi Mandai; Hideo Ishitsuka


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
463 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


classified into two groups based on TNM stage: early and advanced stage disease groups. PD-ECGF expressions in HCC tissues were immunohistologically examined.


๐Ÿ“œ SIMILAR VOLUMES


Expression of platelet-derived endotheli
โœ Youichi Mizutani; Yusaku Okada; Osamu Yoshida ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 1 views

## Background: Angiogenesis is a prerequisite to cancer growth and metastasis and is induced by a variety of angiogenic factors, including platelet-derived endothelial cell growth factor (pdecgf). the authors investigated the expression of pdecgf in 58 initial primary bladder carcinomas. ## Method

Expression of platelet-derived endotheli
โœ Shinsuke Saito; Nelson Tsuno; Hirokazu Nagawa; Eiji Sunami; Jin Zhengxi; Takuya ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 323 KB ๐Ÿ‘ 1 views

## BACKGROUND. Platelet-derived endothelial cell growth factor (PD-ECGF) is an angiogenic factor that has potent chemotactic activity for endothelial cells. Although it is expressed in the majority of colorectal tumors, and some reports suggest that its high expression is related to poor prognosis,